Rank | Gene Set | Z-score |
---|---|---|
1 | polyketide metabolic process (GO:0030638) | 4.89480272 |
2 | doxorubicin metabolic process (GO:0044598) | 4.89480272 |
3 | daunorubicin metabolic process (GO:0044597) | 4.89480272 |
4 | protein localization to kinetochore (GO:0034501) | 4.73643235 |
5 | interferon-gamma production (GO:0032609) | 4.47644139 |
6 | mitotic sister chromatid segregation (GO:0000070) | 4.30778217 |
7 | protein localization to chromosome, centromeric region (GO:0071459) | 4.18821489 |
8 | modulation by virus of host process (GO:0019054) | 4.18607062 |
9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.90683313 |
10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86374648 |
11 | negative regulation of cell killing (GO:0031342) | 3.84957687 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.84957687 |
13 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.77805241 |
14 | sister chromatid segregation (GO:0000819) | 3.74531530 |
15 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.73525068 |
16 | modulation by symbiont of host cellular process (GO:0044068) | 3.67847583 |
17 | negative regulation of telomere maintenance (GO:0032205) | 3.61863948 |
18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57003649 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56620102 |
20 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.53817553 |
21 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40928773 |
22 | detection of bacterium (GO:0016045) | 3.37905010 |
23 | response to peptidoglycan (GO:0032494) | 3.34301134 |
24 | regulation of response to osmotic stress (GO:0047484) | 3.31971220 |
25 | hepatocyte apoptotic process (GO:0097284) | 3.31447235 |
26 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.29737025 |
27 | detection of other organism (GO:0098543) | 3.28666044 |
28 | DNA replication checkpoint (GO:0000076) | 3.28112898 |
29 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.24233473 |
30 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.17511054 |
31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14714482 |
32 | mitotic chromosome condensation (GO:0007076) | 3.12069212 |
33 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.09486034 |
34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07022934 |
35 | cellular response to exogenous dsRNA (GO:0071360) | 3.06738034 |
36 | histone H3-K9 modification (GO:0061647) | 3.05663515 |
37 | response to muramyl dipeptide (GO:0032495) | 3.05399431 |
38 | sperm motility (GO:0030317) | 3.05361480 |
39 | thymic T cell selection (GO:0045061) | 3.05241766 |
40 | cellular extravasation (GO:0045123) | 3.04965222 |
41 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00855703 |
42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.00365648 |
43 | histone H4-K8 acetylation (GO:0043982) | 2.99133502 |
44 | histone H4-K5 acetylation (GO:0043981) | 2.99133502 |
45 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.98956253 |
46 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.97508425 |
47 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.96816084 |
48 | maintenance of protein location in nucleus (GO:0051457) | 2.96705891 |
49 | histone H3-K4 trimethylation (GO:0080182) | 2.96155262 |
50 | B cell receptor signaling pathway (GO:0050853) | 2.95525036 |
51 | cellular response to virus (GO:0098586) | 2.95419554 |
52 | regulation of granulocyte differentiation (GO:0030852) | 2.95303045 |
53 | chromatin assembly (GO:0031497) | 2.95274613 |
54 | germinal center formation (GO:0002467) | 2.94375149 |
55 | modulation by symbiont of host defense response (GO:0052031) | 2.93442333 |
56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93442333 |
57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93442333 |
58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93442333 |
59 | modulation by symbiont of host immune response (GO:0052553) | 2.93442333 |
60 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93442333 |
61 | macrophage activation involved in immune response (GO:0002281) | 2.92613595 |
62 | negative T cell selection (GO:0043383) | 2.92117723 |
63 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.88756613 |
64 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88258048 |
65 | NAD biosynthetic process (GO:0009435) | 2.86391929 |
66 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86062194 |
67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86062194 |
68 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85540372 |
69 | endothelial tube morphogenesis (GO:0061154) | 2.85211793 |
70 | morphogenesis of an endothelium (GO:0003159) | 2.85211793 |
71 | neutrophil activation (GO:0042119) | 2.82664093 |
72 | rRNA methylation (GO:0031167) | 2.82514594 |
73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82176054 |
74 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.81925225 |
75 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.81916301 |
76 | regulation of Rab GTPase activity (GO:0032313) | 2.81784034 |
77 | positive regulation of Rab GTPase activity (GO:0032851) | 2.81784034 |
78 | mannose metabolic process (GO:0006013) | 2.81529104 |
79 | positive regulation of protein deacetylation (GO:0090312) | 2.80297182 |
80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80134593 |
81 | positive regulation of interleukin-2 production (GO:0032743) | 2.80008243 |
82 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79560411 |
83 | heterochromatin organization (GO:0070828) | 2.78846558 |
84 | T cell migration (GO:0072678) | 2.77523967 |
85 | negative regulation of phagocytosis (GO:0050765) | 2.76991973 |
86 | regulation of necroptotic process (GO:0060544) | 2.76466292 |
87 | negative regulation of interleukin-8 production (GO:0032717) | 2.76298588 |
88 | activated T cell proliferation (GO:0050798) | 2.76049159 |
89 | regulation of mast cell degranulation (GO:0043304) | 2.75709425 |
90 | histone H3-K36 demethylation (GO:0070544) | 2.75202553 |
91 | response to type I interferon (GO:0034340) | 2.74876895 |
92 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74662893 |
93 | histone H3-K9 methylation (GO:0051567) | 2.74098620 |
94 | mast cell activation (GO:0045576) | 2.74037643 |
95 | acrosome reaction (GO:0007340) | 2.72824623 |
96 | regulation of B cell differentiation (GO:0045577) | 2.72502470 |
97 | rRNA transcription (GO:0009303) | 2.70560914 |
98 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.70506852 |
99 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.70506852 |
100 | T cell selection (GO:0045058) | 2.70026921 |
101 | NIK/NF-kappaB signaling (GO:0038061) | 2.69794678 |
102 | negative regulation of interleukin-12 production (GO:0032695) | 2.69548660 |
103 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.69496370 |
104 | DNA unwinding involved in DNA replication (GO:0006268) | 2.69145180 |
105 | positive regulation of B cell differentiation (GO:0045579) | 2.69052881 |
106 | negative regulation of epidermis development (GO:0045683) | 2.68624547 |
107 | megakaryocyte development (GO:0035855) | 2.68014110 |
108 | multicellular organism reproduction (GO:0032504) | 2.67786266 |
109 | positive T cell selection (GO:0043368) | 2.67508698 |
110 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.67394084 |
111 | V(D)J recombination (GO:0033151) | 2.67128879 |
112 | establishment of protein localization to Golgi (GO:0072600) | 2.66993137 |
113 | protein localization to chromosome (GO:0034502) | 2.66940086 |
114 | negative regulation of necroptotic process (GO:0060546) | 2.66666537 |
115 | regulation of mast cell activation (GO:0033003) | 2.66508624 |
116 | negative regulation of interleukin-6 production (GO:0032715) | 2.65606140 |
117 | RNA destabilization (GO:0050779) | 2.65259877 |
118 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.65056504 |
119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64816594 |
120 | myeloid cell activation involved in immune response (GO:0002275) | 2.63436745 |
121 | leukocyte degranulation (GO:0043299) | 2.63257271 |
122 | type I interferon signaling pathway (GO:0060337) | 2.62287019 |
123 | cellular response to type I interferon (GO:0071357) | 2.62287019 |
124 | rRNA modification (GO:0000154) | 2.62196251 |
125 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.61429658 |
126 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.61198395 |
127 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.60778300 |
128 | neutrophil activation involved in immune response (GO:0002283) | 2.60728989 |
129 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59955237 |
130 | granulocyte activation (GO:0036230) | 2.59288314 |
131 | positive regulation of isotype switching (GO:0045830) | 2.59150474 |
132 | response to protozoan (GO:0001562) | 2.57777064 |
133 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.57255828 |
134 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.55868445 |
135 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.55857185 |
136 | leukocyte aggregation (GO:0070486) | 2.55840507 |
137 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55632629 |
138 | negative regulation of telomerase activity (GO:0051974) | 2.55317612 |
139 | defense response to protozoan (GO:0042832) | 2.55299323 |
140 | regulation of translation in response to stress (GO:0043555) | 2.54830473 |
141 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.53879704 |
142 | detection of external biotic stimulus (GO:0098581) | 2.53865192 |
143 | cell wall macromolecule metabolic process (GO:0044036) | 2.53583480 |
144 | formation of translation preinitiation complex (GO:0001731) | 2.53152870 |
145 | positive regulation of defense response to virus by host (GO:0002230) | 2.52526315 |
146 | negative regulation of granulocyte differentiation (GO:0030853) | 2.51087394 |
147 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.50908173 |
148 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.50885640 |
149 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.50377714 |
150 | heme biosynthetic process (GO:0006783) | 2.50066496 |
151 | mitotic metaphase plate congression (GO:0007080) | 2.49712956 |
152 | establishment of endothelial barrier (GO:0061028) | 2.49620011 |
153 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.49496596 |
154 | Peyers patch development (GO:0048541) | 2.49496596 |
155 | definitive hemopoiesis (GO:0060216) | 2.49270322 |
156 | neutrophil mediated immunity (GO:0002446) | 2.49244478 |
157 | pore complex assembly (GO:0046931) | 2.48802128 |
158 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.48336257 |
159 | oxygen transport (GO:0015671) | 2.48201159 |
160 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.48163955 |
161 | histone H4-K16 acetylation (GO:0043984) | 2.47511882 |
162 | chromosome condensation (GO:0030261) | 2.46207808 |
163 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.46195981 |
164 | meiotic chromosome segregation (GO:0045132) | 2.46006901 |
165 | positive regulation of histone deacetylation (GO:0031065) | 2.44840760 |
166 | positive thymic T cell selection (GO:0045059) | 2.43681311 |
167 | negative thymic T cell selection (GO:0045060) | 2.42120600 |
168 | regulation of thymocyte apoptotic process (GO:0070243) | 2.41727693 |
169 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.40193851 |
170 | regulation of G0 to G1 transition (GO:0070316) | 2.40114427 |
171 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.38465478 |
172 | DNA deamination (GO:0045006) | 2.38448531 |
173 | DNA duplex unwinding (GO:0032508) | 2.36823570 |
174 | mitotic nuclear envelope disassembly (GO:0007077) | 2.36371643 |
175 | immunoglobulin mediated immune response (GO:0016064) | 2.36367101 |
176 | histone H4-K12 acetylation (GO:0043983) | 2.35916221 |
177 | DNA geometric change (GO:0032392) | 2.35257393 |
178 | modulation by virus of host morphology or physiology (GO:0019048) | 2.33983268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.96338713 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.72567843 |
3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.69584973 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 2.93491475 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.91003237 |
6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.80567082 |
7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.62186604 |
8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55149173 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49211334 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46661813 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.29530715 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21208351 |
13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14205819 |
14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.14171778 |
15 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.14001483 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13288461 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12038667 |
18 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99842131 |
19 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.97602739 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93064356 |
21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.92884254 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91216178 |
23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87739370 |
24 | P68_20966046_ChIP-Seq_HELA_Human | 1.85569676 |
25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83606102 |
26 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82836429 |
27 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.81629336 |
28 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.77247124 |
29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.73486575 |
30 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.70001514 |
31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.69747752 |
32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.68717942 |
33 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67863748 |
34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67679602 |
35 | MAF_26560356_Chip-Seq_TH1_Human | 1.67123188 |
36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65832059 |
37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65694726 |
38 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.65468860 |
39 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.65468860 |
40 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.65468860 |
41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65394712 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64102665 |
43 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64075687 |
44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59746089 |
45 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57411445 |
46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55555938 |
47 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54313065 |
48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53867794 |
49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53086064 |
50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52351916 |
51 | * MYB_26560356_Chip-Seq_TH1_Human | 1.51733576 |
52 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.50646241 |
53 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.49960444 |
54 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.49906404 |
55 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.45783991 |
56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43565685 |
57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42320166 |
58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.41897601 |
59 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40773326 |
60 | P300_27268052_Chip-Seq_Bcells_Human | 1.40728813 |
61 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.40088975 |
62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39913962 |
63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39784651 |
64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.39703314 |
65 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.37565416 |
66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36982122 |
67 | ERA_21632823_ChIP-Seq_H3396_Human | 1.36411516 |
68 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.35910864 |
69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35773690 |
70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33595725 |
71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33532379 |
72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30688968 |
73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30488382 |
74 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30463881 |
75 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30242177 |
76 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28819325 |
77 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.28508702 |
78 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.28252648 |
79 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26827295 |
80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26409456 |
81 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.26408698 |
82 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.25865128 |
83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.25528656 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24834841 |
85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24201770 |
86 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.23735956 |
87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22832123 |
88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22554674 |
89 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21848451 |
90 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21273221 |
91 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.20064554 |
92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19199089 |
93 | * MAF_26560356_Chip-Seq_TH2_Human | 1.18851050 |
94 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18751294 |
95 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18543857 |
96 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17674185 |
97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17205764 |
98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16482276 |
99 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15125863 |
100 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.14826487 |
101 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14742092 |
102 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12713585 |
103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12352754 |
104 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12337039 |
105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11911604 |
106 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11788364 |
107 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.11129218 |
108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10758463 |
109 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09509704 |
110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08995402 |
111 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08856492 |
112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08154881 |
113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08024731 |
114 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08012010 |
115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07219941 |
116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06958012 |
117 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.06910852 |
118 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.06385802 |
119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05827540 |
120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04969485 |
121 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04848025 |
122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04154989 |
123 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04019139 |
124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03887782 |
125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03832474 |
126 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03657596 |
127 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03546561 |
128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03491008 |
129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03467906 |
130 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02207629 |
131 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01660016 |
132 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01599001 |
133 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01399281 |
134 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01084873 |
135 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00751239 |
136 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.00737377 |
137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00686875 |
138 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00539390 |
139 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99934693 |
140 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99373140 |
141 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.99371840 |
142 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99321026 |
143 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99183950 |
144 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.99149987 |
145 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98894996 |
146 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.98421199 |
147 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97463932 |
148 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97356480 |
149 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97168376 |
150 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96883946 |
151 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96745564 |
152 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95910416 |
153 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95575050 |
154 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.95017131 |
155 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94997445 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002396_abnormal_hematopoietic_system | 3.01284690 |
2 | MP0005410_abnormal_fertilization | 2.98884598 |
3 | MP0001835_abnormal_antigen_presentation | 2.79758351 |
4 | MP0005671_abnormal_response_to | 2.74605953 |
5 | MP0008057_abnormal_DNA_replication | 2.73619798 |
6 | MP0003763_abnormal_thymus_physiology | 2.69717295 |
7 | MP0009785_altered_susceptibility_to | 2.59142678 |
8 | MP0003077_abnormal_cell_cycle | 2.42822002 |
9 | MP0000685_abnormal_immune_system | 2.39722763 |
10 | MP0003111_abnormal_nucleus_morphology | 2.38196595 |
11 | MP0002138_abnormal_hepatobiliary_system | 2.34963662 |
12 | MP0004957_abnormal_blastocyst_morpholog | 2.33816279 |
13 | MP0010094_abnormal_chromosome_stability | 2.31958140 |
14 | MP0005083_abnormal_biliary_tract | 2.31327155 |
15 | MP0003693_abnormal_embryo_hatching | 2.24835271 |
16 | MP0002398_abnormal_bone_marrow | 2.24372431 |
17 | MP0001873_stomach_inflammation | 2.23266269 |
18 | MP0003656_abnormal_erythrocyte_physiolo | 2.22272611 |
19 | MP0002132_abnormal_respiratory_system | 2.21940017 |
20 | MP0006082_CNS_inflammation | 2.17826060 |
21 | MP0001800_abnormal_humoral_immune | 2.11799031 |
22 | MP0005075_abnormal_melanosome_morpholog | 2.06160895 |
23 | MP0005000_abnormal_immune_tolerance | 2.02678239 |
24 | MP0003172_abnormal_lysosome_physiology | 2.00621067 |
25 | MP0003646_muscle_fatigue | 2.00579216 |
26 | MP0009333_abnormal_splenocyte_physiolog | 1.97702771 |
27 | MP0000703_abnormal_thymus_morphology | 1.96955790 |
28 | MP0002405_respiratory_system_inflammati | 1.95804624 |
29 | MP0000689_abnormal_spleen_morphology | 1.94504845 |
30 | MP0002722_abnormal_immune_system | 1.93017037 |
31 | MP0004808_abnormal_hematopoietic_stem | 1.91174547 |
32 | MP0002420_abnormal_adaptive_immunity | 1.88526771 |
33 | MP0001819_abnormal_immune_cell | 1.86643714 |
34 | MP0003436_decreased_susceptibility_to | 1.85570903 |
35 | MP0005025_abnormal_response_to | 1.83549036 |
36 | MP0002723_abnormal_immune_serum | 1.83405278 |
37 | MP0005387_immune_system_phenotype | 1.83349275 |
38 | MP0001790_abnormal_immune_system | 1.83349275 |
39 | MP0002452_abnormal_antigen_presenting | 1.83239720 |
40 | MP0000490_abnormal_crypts_of | 1.83234334 |
41 | MP0000716_abnormal_immune_system | 1.83166979 |
42 | MP0003011_delayed_dark_adaptation | 1.81506952 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.80142721 |
44 | MP0002429_abnormal_blood_cell | 1.75602177 |
45 | MP0004381_abnormal_hair_follicle | 1.74688935 |
46 | MP0005670_abnormal_white_adipose | 1.71982443 |
47 | MP0004264_abnormal_extraembryonic_tissu | 1.71824901 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.67616175 |
49 | MP0001545_abnormal_hematopoietic_system | 1.67616175 |
50 | MP0009278_abnormal_bone_marrow | 1.58754076 |
51 | MP0008007_abnormal_cellular_replicative | 1.58373998 |
52 | MP0005394_taste/olfaction_phenotype | 1.54430069 |
53 | MP0005499_abnormal_olfactory_system | 1.54430069 |
54 | MP0002148_abnormal_hypersensitivity_rea | 1.53687159 |
55 | MP0010155_abnormal_intestine_physiology | 1.50280256 |
56 | MP0001986_abnormal_taste_sensitivity | 1.49399131 |
57 | MP0006292_abnormal_olfactory_placode | 1.48020829 |
58 | MP0004130_abnormal_muscle_cell | 1.47596912 |
59 | MP0004947_skin_inflammation | 1.46689131 |
60 | MP0005377_hearing/vestibular/ear_phenot | 1.44214666 |
61 | MP0003878_abnormal_ear_physiology | 1.44214666 |
62 | MP0001533_abnormal_skeleton_physiology | 1.39543218 |
63 | MP0003866_abnormal_defecation | 1.36170418 |
64 | MP0000858_altered_metastatic_potential | 1.35125790 |
65 | MP0002254_reproductive_system_inflammat | 1.33841587 |
66 | MP0002419_abnormal_innate_immunity | 1.32474403 |
67 | MP0003045_fibrosis | 1.31384567 |
68 | MP0002019_abnormal_tumor_incidence | 1.30941509 |
69 | MP0000313_abnormal_cell_death | 1.27800742 |
70 | MP0002009_preneoplasia | 1.27322645 |
71 | MP0008995_early_reproductive_senescence | 1.25728458 |
72 | MP0000350_abnormal_cell_proliferation | 1.24089789 |
73 | MP0008961_abnormal_basal_metabolism | 1.23978784 |
74 | MP0008058_abnormal_DNA_repair | 1.22340214 |
75 | MP0001853_heart_inflammation | 1.22059180 |
76 | MP0001849_ear_inflammation | 1.21951983 |
77 | MP0005076_abnormal_cell_differentiation | 1.21365483 |
78 | MP0001348_abnormal_lacrimal_gland | 1.15292027 |
79 | MP0003698_abnormal_male_reproductive | 1.11560571 |
80 | MP0003448_altered_tumor_morphology | 1.10877312 |
81 | MP0006035_abnormal_mitochondrial_morpho | 1.10757845 |
82 | MP0001845_abnormal_inflammatory_respons | 1.10443504 |
83 | MP0002653_abnormal_ependyma_morphology | 1.09605028 |
84 | MP0005464_abnormal_platelet_physiology | 1.09472427 |
85 | MP0009115_abnormal_fat_cell | 1.08925452 |
86 | MP0002006_tumorigenesis | 1.07549909 |
87 | MP0002166_altered_tumor_susceptibility | 1.07031022 |
88 | MP0003890_abnormal_embryonic-extraembry | 1.06339000 |
89 | MP0002933_joint_inflammation | 1.06036233 |
90 | MP0005380_embryogenesis_phenotype | 1.03144622 |
91 | MP0001672_abnormal_embryogenesis/_devel | 1.03144622 |
92 | MP0003984_embryonic_growth_retardation | 1.02441739 |
93 | MP0002088_abnormal_embryonic_growth/wei | 1.02082085 |
94 | MP0005310_abnormal_salivary_gland | 0.97150001 |
95 | MP0003183_abnormal_peptide_metabolism | 0.97132652 |
96 | MP0001929_abnormal_gametogenesis | 0.96375024 |
97 | MP0004858_abnormal_nervous_system | 0.94107863 |
98 | MP0003121_genomic_imprinting | 0.89370468 |
99 | MP0000343_altered_response_to | 0.86517967 |
100 | MP0003300_gastrointestinal_ulcer | 0.86514077 |
101 | MP0003303_peritoneal_inflammation | 0.85361407 |
102 | MP0005666_abnormal_adipose_tissue | 0.84815284 |
103 | MP0005167_abnormal_blood-brain_barrier | 0.83417899 |
104 | MP0008789_abnormal_olfactory_epithelium | 0.83328904 |
105 | MP0002127_abnormal_cardiovascular_syste | 0.83203416 |
106 | MP0003787_abnormal_imprinting | 0.83111786 |
107 | MP0001730_embryonic_growth_arrest | 0.82494836 |
108 | MP0009764_decreased_sensitivity_to | 0.82402004 |
109 | MP0004147_increased_porphyrin_level | 0.82265075 |
110 | MP0002086_abnormal_extraembryonic_tissu | 0.82088100 |
111 | MP0003705_abnormal_hypodermis_morpholog | 0.81769158 |
112 | MP0002095_abnormal_skin_pigmentation | 0.81716904 |
113 | MP0001663_abnormal_digestive_system | 0.81549158 |
114 | MP0004510_myositis | 0.80520907 |
115 | MP0003186_abnormal_redox_activity | 0.80206142 |
116 | MP0004185_abnormal_adipocyte_glucose | 0.80138079 |
117 | MP0001765_abnormal_ion_homeostasis | 0.80039069 |
118 | MP0009840_abnormal_foam_cell | 0.79990655 |
119 | MP0001243_abnormal_dermal_layer | 0.78921142 |
120 | MP0008469_abnormal_protein_level | 0.76977750 |
121 | MP0000465_gastrointestinal_hemorrhage | 0.75658018 |
122 | MP0003828_pulmonary_edema | 0.75250464 |
123 | MP0002080_prenatal_lethality | 0.74952207 |
124 | MP0003724_increased_susceptibility_to | 0.74751366 |
125 | MP0005174_abnormal_tail_pigmentation | 0.74409600 |
126 | MP0005375_adipose_tissue_phenotype | 0.74325806 |
127 | MP0000678_abnormal_parathyroid_gland | 0.72570485 |
128 | MP0000003_abnormal_adipose_tissue | 0.72434919 |
129 | MP0002332_abnormal_exercise_endurance | 0.71347417 |
130 | MP0000358_abnormal_cell_content/ | 0.70461896 |
131 | MP0000371_diluted_coat_color | 0.70113182 |
132 | MP0005257_abnormal_intraocular_pressure | 0.70038154 |
133 | MP0008877_abnormal_DNA_methylation | 0.69369283 |
134 | MP0000015_abnormal_ear_pigmentation | 0.67896725 |
135 | MP0010307_abnormal_tumor_latency | 0.67807958 |
136 | MP0005334_abnormal_fat_pad | 0.67466976 |
137 | MP0005058_abnormal_lysosome_morphology | 0.66741532 |
138 | MP0008932_abnormal_embryonic_tissue | 0.66237117 |
139 | MP0002998_abnormal_bone_remodeling | 0.64095854 |
140 | MP0009765_abnormal_xenobiotic_induced | 0.63833508 |
141 | MP0005451_abnormal_body_composition | 0.63664071 |
142 | MP0002928_abnormal_bile_duct | 0.63608224 |
143 | MP0002249_abnormal_larynx_morphology | 0.63323632 |
144 | MP0000609_abnormal_liver_physiology | 0.62984621 |
145 | MP0000470_abnormal_stomach_morphology | 0.62159580 |
146 | MP0002168_other_aberrant_phenotype | 0.61624282 |
147 | MP0008260_abnormal_autophagy | 0.60725564 |
148 | MP0000249_abnormal_blood_vessel | 0.54636311 |
149 | MP0005390_skeleton_phenotype | 0.54136447 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Combined immunodeficiency (HP:0005387) | 5.02109061 |
2 | Hypochromic microcytic anemia (HP:0004840) | 4.50504184 |
3 | Panhypogammaglobulinemia (HP:0003139) | 4.25351446 |
4 | T lymphocytopenia (HP:0005403) | 4.16550820 |
5 | Abnormality of T cell number (HP:0011839) | 4.04606973 |
6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.02469770 |
7 | B lymphocytopenia (HP:0010976) | 4.01566937 |
8 | Abnormality of B cell number (HP:0010975) | 4.01566937 |
9 | Severe combined immunodeficiency (HP:0004430) | 3.81836789 |
10 | Recurrent viral infections (HP:0004429) | 3.78854127 |
11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.75250322 |
12 | Nasal polyposis (HP:0100582) | 3.68261841 |
13 | Optic neuritis (HP:0100653) | 3.60474649 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.60474649 |
15 | Multiple enchondromatosis (HP:0005701) | 3.56569854 |
16 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.48074538 |
17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.46018238 |
18 | Stomatitis (HP:0010280) | 3.45518513 |
19 | Bilateral microphthalmos (HP:0007633) | 3.45089168 |
20 | Attenuation of retinal blood vessels (HP:0007843) | 3.42699074 |
21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.42320813 |
22 | Eosinophilia (HP:0001880) | 3.40371088 |
23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31136660 |
24 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.29732453 |
25 | Severe visual impairment (HP:0001141) | 3.23368744 |
26 | Abnormality of the nasal mucosa (HP:0000433) | 3.20954024 |
27 | Hypoplasia of the thymus (HP:0000778) | 3.11838204 |
28 | Increased cerebral lipofuscin (HP:0011813) | 3.11603784 |
29 | Gastrointestinal infarctions (HP:0005244) | 3.10657785 |
30 | Myositis (HP:0100614) | 3.07366270 |
31 | Thyroiditis (HP:0100646) | 3.07320340 |
32 | Abnormality of T cells (HP:0002843) | 3.03829425 |
33 | Chromsome breakage (HP:0040012) | 3.03628998 |
34 | Recurrent fungal infections (HP:0002841) | 3.03317291 |
35 | Hypochromic anemia (HP:0001931) | 3.01049324 |
36 | Granulocytopenia (HP:0001913) | 2.99769024 |
37 | Genetic anticipation (HP:0003743) | 2.94904758 |
38 | Abnormality of macrophages (HP:0004311) | 2.87834078 |
39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72571899 |
40 | Obstructive lung disease (HP:0006536) | 2.72571899 |
41 | Abnormality of eosinophils (HP:0001879) | 2.64794777 |
42 | Clumsiness (HP:0002312) | 2.62337012 |
43 | Encephalitis (HP:0002383) | 2.60050524 |
44 | Abnormality of the fingertips (HP:0001211) | 2.57333002 |
45 | Leukocytosis (HP:0001974) | 2.57205561 |
46 | Pendular nystagmus (HP:0012043) | 2.54203520 |
47 | Keratoconjunctivitis (HP:0001096) | 2.53417270 |
48 | Recurrent bronchitis (HP:0002837) | 2.53084993 |
49 | IgG deficiency (HP:0004315) | 2.52933048 |
50 | Recurrent skin infections (HP:0001581) | 2.50652056 |
51 | Reduced antithrombin III activity (HP:0001976) | 2.47416042 |
52 | Keratoconjunctivitis sicca (HP:0001097) | 2.46429204 |
53 | Orchitis (HP:0100796) | 2.45630938 |
54 | Myelodysplasia (HP:0002863) | 2.45603604 |
55 | Broad palm (HP:0001169) | 2.44141962 |
56 | Chronic otitis media (HP:0000389) | 2.43304152 |
57 | Gingivitis (HP:0000230) | 2.42307229 |
58 | Hemoptysis (HP:0002105) | 2.40643535 |
59 | Colitis (HP:0002583) | 2.38433297 |
60 | Inflammation of the large intestine (HP:0002037) | 2.37171435 |
61 | Abnormality of the lower motor neuron (HP:0002366) | 2.36993285 |
62 | Increased IgE level (HP:0003212) | 2.36475893 |
63 | Rib fusion (HP:0000902) | 2.35878391 |
64 | IgM deficiency (HP:0002850) | 2.35876456 |
65 | Meckel diverticulum (HP:0002245) | 2.35224750 |
66 | Recurrent abscess formation (HP:0002722) | 2.34636394 |
67 | Microcytic anemia (HP:0001935) | 2.32715124 |
68 | Pulmonary infiltrates (HP:0002113) | 2.32515729 |
69 | Gastrointestinal inflammation (HP:0004386) | 2.32078710 |
70 | Hepatoblastoma (HP:0002884) | 2.31043441 |
71 | Microretrognathia (HP:0000308) | 2.30665230 |
72 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.29910882 |
73 | Cellulitis (HP:0100658) | 2.26562088 |
74 | Abnormality of the ileum (HP:0001549) | 2.26472072 |
75 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.25639446 |
76 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.25540264 |
77 | Abnormality of DNA repair (HP:0003254) | 2.23775342 |
78 | Eczematoid dermatitis (HP:0000976) | 2.22347113 |
79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21134500 |
80 | Petechiae (HP:0000967) | 2.20697449 |
81 | Abnormality of the intervertebral disk (HP:0005108) | 2.20674215 |
82 | Spontaneous hematomas (HP:0007420) | 2.17270567 |
83 | Aplastic anemia (HP:0001915) | 2.14270685 |
84 | Reticulocytosis (HP:0001923) | 2.13422359 |
85 | Epistaxis (HP:0000421) | 2.13087912 |
86 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.12109609 |
87 | Abnormality of the columella (HP:0009929) | 2.11433013 |
88 | Pustule (HP:0200039) | 2.11210084 |
89 | Hypoproteinemia (HP:0003075) | 2.11113830 |
90 | Intestinal fistula (HP:0100819) | 2.11055122 |
91 | Abnormality of iron homeostasis (HP:0011031) | 2.09340722 |
92 | Increased IgM level (HP:0003496) | 2.07310505 |
93 | Paralysis (HP:0003470) | 2.07288467 |
94 | Rhabdomyosarcoma (HP:0002859) | 2.06765790 |
95 | Lymphoma (HP:0002665) | 2.06419458 |
96 | Abnormal lung lobation (HP:0002101) | 2.06380588 |
97 | Poikilocytosis (HP:0004447) | 2.05412067 |
98 | Autoimmune thrombocytopenia (HP:0001973) | 2.03424321 |
99 | Embryonal renal neoplasm (HP:0011794) | 2.02792509 |
100 | Recurrent bacterial skin infections (HP:0005406) | 2.02457230 |
101 | Stomach cancer (HP:0012126) | 2.02212001 |
102 | Ependymoma (HP:0002888) | 2.00369969 |
103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00043124 |
104 | Progressive cerebellar ataxia (HP:0002073) | 1.99383805 |
105 | Congenital stationary night blindness (HP:0007642) | 1.98645956 |
106 | Short 5th finger (HP:0009237) | 1.98168477 |
107 | Agammaglobulinemia (HP:0004432) | 1.97743123 |
108 | Preauricular skin tag (HP:0000384) | 1.96165689 |
109 | Polycythemia (HP:0001901) | 1.95442964 |
110 | Increased serum ferritin (HP:0003281) | 1.95174261 |
111 | Hypertensive crisis (HP:0100735) | 1.94456605 |
112 | Small intestinal stenosis (HP:0012848) | 1.94246731 |
113 | Duodenal stenosis (HP:0100867) | 1.94246731 |
114 | Arterial thrombosis (HP:0004420) | 1.93084747 |
115 | Neoplasm of striated muscle (HP:0009728) | 1.92588804 |
116 | Chronic hepatic failure (HP:0100626) | 1.92203813 |
117 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.92017633 |
118 | Meningitis (HP:0001287) | 1.91666004 |
119 | Abnormality of the pleura (HP:0002103) | 1.91601573 |
120 | Abnormality of the nasal septum (HP:0000419) | 1.91263241 |
121 | Mesomelia (HP:0003027) | 1.88982278 |
122 | Bone marrow hypocellularity (HP:0005528) | 1.88431663 |
123 | Hypoplasia of the fovea (HP:0007750) | 1.88384757 |
124 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.88384757 |
125 | Abnormality of the preputium (HP:0100587) | 1.88024428 |
126 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.87837959 |
127 | Truncal obesity (HP:0001956) | 1.87488480 |
128 | Type I transferrin isoform profile (HP:0003642) | 1.87193899 |
129 | Prostate neoplasm (HP:0100787) | 1.86095955 |
130 | Abnormality of chromosome segregation (HP:0002916) | 1.85608672 |
131 | Tented upper lip vermilion (HP:0010804) | 1.84577774 |
132 | Abnormality of T cell physiology (HP:0011840) | 1.84327770 |
133 | Autoimmune hemolytic anemia (HP:0001890) | 1.83753248 |
134 | Acute hepatic failure (HP:0006554) | 1.80994513 |
135 | Skin tags (HP:0010609) | 1.80796588 |
136 | Generalized hypotonia (HP:0001290) | 1.79756870 |
137 | Rectal fistula (HP:0100590) | 1.79637907 |
138 | Rectovaginal fistula (HP:0000143) | 1.79637907 |
139 | Trismus (HP:0000211) | 1.79086524 |
140 | Hypoplastic ischia (HP:0003175) | 1.78773956 |
141 | Asymmetric septal hypertrophy (HP:0001670) | 1.77867231 |
142 | Cheilitis (HP:0100825) | 1.76817310 |
143 | Abnormality of reticulocytes (HP:0004312) | 1.75499441 |
144 | Thrombocytosis (HP:0001894) | 1.73290584 |
145 | Mediastinal lymphadenopathy (HP:0100721) | 1.73261515 |
146 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73072840 |
147 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73072840 |
148 | Vasculitis (HP:0002633) | 1.72674917 |
149 | Urticaria (HP:0001025) | 1.70536600 |
150 | Anorexia (HP:0002039) | 1.69776791 |
151 | Keratitis (HP:0000491) | 1.69059861 |
152 | Prolonged bleeding time (HP:0003010) | 1.68161900 |
153 | Patellar aplasia (HP:0006443) | 1.67059015 |
154 | Sloping forehead (HP:0000340) | 1.67039221 |
155 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.65826417 |
156 | Short 1st metacarpal (HP:0010034) | 1.65826417 |
157 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.65825681 |
158 | Chest pain (HP:0100749) | 1.64759270 |
159 | Partial duplication of thumb phalanx (HP:0009944) | 1.64577723 |
160 | Increased nuchal translucency (HP:0010880) | 1.64273534 |
161 | Hyperkalemia (HP:0002153) | 1.63413606 |
162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.62985047 |
163 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62985047 |
164 | Ectopic kidney (HP:0000086) | 1.62308290 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 5.68803619 |
2 | MAP4K1 | 3.38501625 |
3 | GRK6 | 3.31195195 |
4 | ERN1 | 3.20292849 |
5 | STK10 | 2.84368406 |
6 | RIPK4 | 2.73686950 |
7 | MAP3K10 | 2.73199587 |
8 | CSF1R | 2.67802957 |
9 | TXK | 2.34824838 |
10 | FRK | 2.26745588 |
11 | BUB1 | 2.13586037 |
12 | TAOK3 | 2.06714089 |
13 | GRK5 | 1.98241740 |
14 | TNK2 | 1.94540967 |
15 | MAPK7 | 1.88461101 |
16 | ADRBK2 | 1.70972334 |
17 | TGFBR2 | 1.66717093 |
18 | MAP3K14 | 1.65232934 |
19 | FES | 1.63026829 |
20 | PIM2 | 1.59891789 |
21 | MAP3K11 | 1.58075940 |
22 | ZAP70 | 1.55975535 |
23 | RIPK1 | 1.55289140 |
24 | ITK | 1.50113363 |
25 | MAPK15 | 1.42694337 |
26 | NEK2 | 1.42105254 |
27 | TLK1 | 1.40537414 |
28 | TTK | 1.39609670 |
29 | TBK1 | 1.35690308 |
30 | KIT | 1.34441974 |
31 | GRK1 | 1.33542463 |
32 | CAMK1D | 1.33156333 |
33 | INSRR | 1.33134934 |
34 | EEF2K | 1.32671191 |
35 | MAP3K13 | 1.32124834 |
36 | AKT3 | 1.29264576 |
37 | CDC7 | 1.25903433 |
38 | TYK2 | 1.24454197 |
39 | IKBKB | 1.21908271 |
40 | BLK | 1.16806877 |
41 | CSK | 1.15824682 |
42 | PDK1 | 1.14779462 |
43 | MAPK11 | 1.13203671 |
44 | MATK | 1.12307309 |
45 | PAK4 | 1.09752855 |
46 | BTK | 1.09173375 |
47 | SYK | 1.08464781 |
48 | PLK1 | 1.08349013 |
49 | JAK3 | 1.07836725 |
50 | IKBKE | 1.05883748 |
51 | CDK7 | 1.05482706 |
52 | PIM1 | 1.04931249 |
53 | BRSK1 | 1.04073105 |
54 | CHUK | 1.02323152 |
55 | RPS6KA6 | 1.02119814 |
56 | MAP3K3 | 1.02026445 |
57 | PDPK1 | 1.01270236 |
58 | BRD4 | 1.00759426 |
59 | CAMK1G | 0.99908486 |
60 | PLK4 | 0.99279251 |
61 | KDR | 0.98256581 |
62 | STK38 | 0.98253917 |
63 | FLT3 | 0.92323893 |
64 | IRAK1 | 0.91907034 |
65 | MAP2K2 | 0.91659465 |
66 | ICK | 0.90579464 |
67 | STK4 | 0.89492631 |
68 | ACVR1B | 0.88594295 |
69 | HCK | 0.86167643 |
70 | RPS6KL1 | 0.85092295 |
71 | RPS6KC1 | 0.85092295 |
72 | PRKD2 | 0.85063915 |
73 | BMPR1B | 0.84150767 |
74 | TESK2 | 0.83245492 |
75 | MOS | 0.82959436 |
76 | LCK | 0.82548948 |
77 | MAP3K7 | 0.82496898 |
78 | SIK3 | 0.82081796 |
79 | HIPK2 | 0.80935583 |
80 | DYRK3 | 0.80572516 |
81 | SIK1 | 0.80526469 |
82 | PRKG2 | 0.80328754 |
83 | JAK2 | 0.79150891 |
84 | PIK3CG | 0.76593532 |
85 | WEE1 | 0.76021813 |
86 | BRSK2 | 0.75681138 |
87 | TAOK2 | 0.75103410 |
88 | CAMK4 | 0.74508961 |
89 | MAP3K1 | 0.74429460 |
90 | AURKB | 0.74196241 |
91 | DYRK1B | 0.73523996 |
92 | CHEK2 | 0.73453694 |
93 | RPS6KB2 | 0.73020968 |
94 | PRKAA2 | 0.71785266 |
95 | ATR | 0.71756056 |
96 | * CHEK1 | 0.68323789 |
97 | RPS6KA4 | 0.68056724 |
98 | GRK7 | 0.67513018 |
99 | JAK1 | 0.66649973 |
100 | FGFR3 | 0.65249869 |
101 | WNK1 | 0.63629719 |
102 | MAP2K3 | 0.63167962 |
103 | CDK4 | 0.62606951 |
104 | IRAK3 | 0.62513518 |
105 | CDC42BPA | 0.62370939 |
106 | CLK1 | 0.62067062 |
107 | YES1 | 0.60779081 |
108 | EPHB1 | 0.60237539 |
109 | RPS6KA2 | 0.60019664 |
110 | AKT2 | 0.59898454 |
111 | MELK | 0.59662248 |
112 | PTK2B | 0.58994026 |
113 | SIK2 | 0.58671503 |
114 | EIF2AK1 | 0.58591419 |
115 | MTOR | 0.58526852 |
116 | MARK3 | 0.58170220 |
117 | IRAK4 | 0.57830497 |
118 | EIF2AK2 | 0.57797477 |
119 | MAPKAPK2 | 0.57035468 |
120 | TEC | 0.56724654 |
121 | STK16 | 0.55295122 |
122 | LYN | 0.53230158 |
123 | TAOK1 | 0.52882544 |
124 | TRPM7 | 0.51482571 |
125 | SGK2 | 0.51448608 |
126 | LRRK2 | 0.51293860 |
127 | SGK3 | 0.50803951 |
128 | PRPF4B | 0.50210248 |
129 | MARK2 | 0.49473971 |
130 | PTK6 | 0.49118815 |
131 | STK11 | 0.48256798 |
132 | MAP3K8 | 0.48186747 |
133 | MAPK12 | 0.47986808 |
134 | MAPK13 | 0.46916788 |
135 | TYRO3 | 0.46435239 |
136 | EPHA3 | 0.46315645 |
137 | NLK | 0.44797875 |
138 | SRPK1 | 0.44703998 |
139 | MAPK4 | 0.44528908 |
140 | IRAK2 | 0.44390705 |
141 | MUSK | 0.43982060 |
142 | CDK9 | 0.43911012 |
143 | MAPK8 | 0.43697740 |
144 | MAP2K6 | 0.43529581 |
145 | PKN2 | 0.43126195 |
146 | ZAK | 0.42779339 |
147 | PRKCQ | 0.40126157 |
148 | FGFR4 | 0.36951252 |
149 | TRIB3 | 0.36671631 |
150 | TGFBR1 | 0.36411592 |
151 | CDK2 | 0.35910532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.68647289 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.82512970 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29561866 |
4 | Base excision repair_Homo sapiens_hsa03410 | 2.21060609 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.12741535 |
6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94116969 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 1.91117602 |
8 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.86921452 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 1.86895179 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84450761 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84379130 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83328277 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83282928 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83155037 |
15 | Cell cycle_Homo sapiens_hsa04110 | 1.77799022 |
16 | Measles_Homo sapiens_hsa05162 | 1.77670567 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75900435 |
18 | Mismatch repair_Homo sapiens_hsa03430 | 1.72641638 |
19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72389132 |
20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64041416 |
21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.60538435 |
22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57555613 |
23 | Spliceosome_Homo sapiens_hsa03040 | 1.56812547 |
24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55559678 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52285323 |
26 | RNA transport_Homo sapiens_hsa03013 | 1.48920713 |
27 | RNA degradation_Homo sapiens_hsa03018 | 1.44761890 |
28 | Apoptosis_Homo sapiens_hsa04210 | 1.44594668 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43755953 |
30 | Legionellosis_Homo sapiens_hsa05134 | 1.43495807 |
31 | Proteasome_Homo sapiens_hsa03050 | 1.41384821 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.34414582 |
33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33810397 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26346706 |
35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.25565646 |
36 | Malaria_Homo sapiens_hsa05144 | 1.24910446 |
37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24884435 |
38 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.22318371 |
39 | ABC transporters_Homo sapiens_hsa02010 | 1.20629872 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19925625 |
41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16650922 |
42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15634286 |
43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15368803 |
44 | Influenza A_Homo sapiens_hsa05164 | 1.15176291 |
45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.15163853 |
46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15129095 |
47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12660320 |
48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09358484 |
49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06214362 |
50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03953358 |
51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03588980 |
52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02970459 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02939003 |
54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02525342 |
55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01358148 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00055456 |
57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99715957 |
58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98093799 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97149523 |
60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95169987 |
61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94074367 |
62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93223787 |
63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92942226 |
64 | Hepatitis B_Homo sapiens_hsa05161 | 0.92359255 |
65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92305671 |
66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91862322 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88895805 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 0.88819266 |
69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88775775 |
70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88398236 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88227636 |
72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86525363 |
73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85599538 |
74 | Ribosome_Homo sapiens_hsa03010 | 0.85016045 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.84738865 |
76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84100742 |
77 | Platelet activation_Homo sapiens_hsa04611 | 0.83202925 |
78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79725242 |
79 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79342198 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78532002 |
81 | Tuberculosis_Homo sapiens_hsa05152 | 0.78446871 |
82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78128784 |
83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77849750 |
84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77129023 |
85 | RNA polymerase_Homo sapiens_hsa03020 | 0.76700602 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76602849 |
87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75388838 |
88 | Lysosome_Homo sapiens_hsa04142 | 0.73165200 |
89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71863560 |
90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68927295 |
91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67494012 |
92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.66813776 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66496610 |
94 | Shigellosis_Homo sapiens_hsa05131 | 0.64915861 |
95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64348642 |
96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63569975 |
97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62764973 |
98 | Lysine degradation_Homo sapiens_hsa00310 | 0.62519915 |
99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62493805 |
100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62375436 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62048183 |
102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61949818 |
103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61358701 |
104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61154165 |
105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61028382 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60623854 |
107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60565650 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59778129 |
109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58901250 |
110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58167128 |
111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56550195 |
112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55044914 |
113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54920835 |
114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54865135 |
115 | Pertussis_Homo sapiens_hsa05133 | 0.53604710 |
116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53151006 |
117 | Asthma_Homo sapiens_hsa05310 | 0.52889153 |
118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52532724 |
119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51878698 |
120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50566515 |
121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50553723 |
122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50130012 |
123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49819187 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49499619 |
125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49204380 |
126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47771010 |
127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47571548 |
128 | Endocytosis_Homo sapiens_hsa04144 | 0.47416878 |
129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47247597 |
130 | Prostate cancer_Homo sapiens_hsa05215 | 0.45383705 |
131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44764530 |
132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44177954 |
133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44143724 |
134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43912092 |
135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42855201 |
136 | Salmonella infection_Homo sapiens_hsa05132 | 0.42017866 |
137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34578567 |
138 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.31891088 |
139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30816193 |